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THE fact that certain aromatic amines were ascribed as causative agents for
the bladder cancer amongst dyestuff workers has now been established. Bladder
cancer was also experimentally induced in animals by administration of 2-
naphythylamine, 4-aminophenol hydrazobenzene, aminoazotoluene and its
dimethyl derivative and xenylamine (Hueper, 1938; Nelson and Woodard,
1953; Walpole, Williams and Roberts, 1954). The carcinoginic effect of these
aromatic amines on the urinary bladder is mainly due to the excretion of certain
metabolites of these amines in the urine. Some ortho-aminophenols which are
normal products of endogenous metabolism of tryptophan and which naturally
occur in small amounts in human urine are now known to induce bladder cancer
(Allen, Boyland, Dukes, Hornings and Watson, 1957; Boyland and Manson,
1958).
In view of the high incidence of bladder cancer in Egypt together with the
widespread urinary bilharzial infection it appeared desirable to find out whether
any of the carcinogenic metabolites are associated with and might be responsible
for the production of bladder cancer in this country.
The liver is known to be the main site of metabolism of such compounds.
Variable degrees ranging from mild to severe liver disturbances have been shown
to be accompanied with simple and complicated bilharzial affections (Abul-Fadl
and Abdin, 1952: Mousa and El-Garem, 1959).
The role of certain enzymes particularly the /3-glucuronidase in the mechanism
of the production of cancer of the bladder has been frequently discussed (Boyland,
WAallace and Williams, 1957; Boyland, Gasson and Williams, 1957). The livei
-also seems to be actively involved in the production of such enzymes.
For these reasons we felt it necessary to start an extensive study of the urinary
excretion of certain tryptophan metabolites together with ,8-glucoronidase, acid
and alkaline phosphatase as well as the blood serum levels of transaminases,
alkaline phosphatases and other necessary liver function tests.
The present communication is a preliminary report on the results so far
obtained concerning tryptophan metabolites excretion on a total of 220 cases
comprising simple urinary bilharziasis (35) bilharzial hepatosplenomegalies (60);
bladder cancer with active or bilharzial history (75) and normal subjects (50).
Table I shows the urinary excretion of certain tryptophan metabolites in the
above mentioned cases.
The level of excretion of 3-hydroxy-anthranilic acid amongst Egyptians seems
to be lower than that described elsewhere. This has been also confirmed byM. A. M. ABUL-FADL AND A. S. KHALAFALLAH
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EHTRYPTOPHAN METABOLITES IN BILHARZIASIS
-Professor E. Boyland at the Chester Beatty Laboratories where he kindly con-
ducted a series of determinations of 3-hydroxyanthranilic acid on samples of
urines preserved with acid and flown from Cairo to London. Nevertheless, a
relative increase in this metabolite was shown to occur in both simple and com-
plicated bilharziasis to about twice the average normal.
In bladder cancer with urinary bilharzial history the average excretion of this
metabolite was increased to four times as much as the normal.
The changes in serotonin (5-hydroxy-tryptamine), are more interesting.
Bilharzial infection whether simple or complicated caused a marked increase in
serotonin excretion (about 3 times as much as the average normal). In cancer
of the bladder the increase was even greater (about 10 fold).
Serotonin has also been found to increase in certain deficiency diseases, e.g.
pellagra, and was found to diminish with nicotinic acid treatment. The carcino-
genic activity ofserotonin has not yet been established. Nevertheless its presence
in such considerable amounts in urines from bladder cancer persons is verv
suggestive of an important nutritional factor in this disease. Such a nutritional
factor would probably contribute towards the establishment and proliferation
of bladder cancer.
The excretion of anthranilic acid, indol-3-acetic acid and kynurenine in
bilharzial and bladder cancer patients, showed no significant variation from the
excretion ofthese metabolites in normals.
TABLE II.-Excretion of Tryptophan Metabolites in Normal Egyptians
(L-Tryptophan 100 mg./kg. body weight)
After administration of Tryptophan
Before (100 mg./kg. body weight)
adminis- ,-
tration Total
of excretion
Trypto- 1st 2nd 3rd 4th 5th 6th Rest of metabo.
phan hr. hr. hr. hr. hr. hr. 24 hr. lites
Volume of urines 900 130 70 100 85 200 110 380 1075
(ml.)
Serotonin 5 - OH - 13-5 1- 56 2- 64 6 1 - 357 0 75 0 74 7 - 98 21 - 22
Tryptamine (mg.)
Indol 3-acetic acid 6- 75 1-16 1- 5 2 - 5 1-9 1-9 1-1 3- 26 13- 32
(mg.)
Kynurenine (mg.) 1-12 0-46 0 88 1-56 1-08 1-0 0-95 1-9 7-77
:3 - OH Anthranilic 0 85 0-16 0-18 0-36 0-19 0-19 0-16 0-7 1-94
acid (mg.)
Table II gives the average excretion of the above metabolites after adminis-
tration of L-tryptophan (100 mg/kg. body weight) to average Egyptian subjects.
'The results of this experiment with bilharzial and bladder cancer patients are
not yet available.
This presentation of work in progress, suggests the use of oral and parenteral
nicotinamide and its derivatives in a wide-scale trial for bilharzial and bladder
cancer patients in Egypt. This might be helpful not only for prevention but also
for treatment of this disease during its preliminary stages.
Serotonin was estimated colorimetrically by the method of Macfarlane and
others (1956).
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Indol-3-acetic acid was assayed by the colorimetric method of Weissbach, and
others (1959).
For 3-hydroxy-anthranilic acid, anthranilic acid andkynurenine determinations
the technique described by Tompsett (1959) was followed.
Kynurenic and xanthurenic acids were determined by the method of Satoh
and Price (1958).
SUMMARY
A preliminary report on the urinary secretion of certain tryptophan meta-
bolites, in 220 cases, is presented. Results showed an increase of 3-hydroxy-
anthranilic acid to twice the normal levels in cases of bilharzial affections, and
to four times in bilharzial cancers of the bladder. Serotonin excretion was
increased threefold and tenfold respectively. No significant changes in secretion
of anthranilic acid, indol-3-acetic acid and kynurenine were detected.
The authors wish to take this opportunity to express their sincere thanks to
Professor A. Haddow and to Professor E. Boyland ofthe Chester-Beatty Research
Institute, London for supplying certain materials without which this study would
not have been made possible.
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